0
2020
Hydroxychloroquine Market

Hydroxychloroquine Market

by Product type (Tablet and Active Pharmaceutical Ingredients), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Specialty Drug Store, and Retail Pharmacy), and Disease (Malaria, Rheumatoid Arthritis, Lupus Erythematosus, Coronavirus, and Others): Global Opportunity Analysis and Industry Forecast, 2020-2027
Update Available On-Demand

Report Code: A07137
Pages: 246
Sep 2020 | 5690 Views
Author(s) : Yamini P , Eswara P
Tables: 120
Charts: 73
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Hydroxychloroquine Market

Request Now !

Hydroxychloroquine Market Outlook - 2027

The global hydroxychloroquine market size was valued at $1.9 billion in 2019, and is anticipated to generate $4.6 billion by 2027. The market is projected to experience growth at a CAGR of 7.9% from 2020 to 2027.  

Hydroxychloroquine is being used in treatment of COVID-19 patients since the initial stage during the wake of the pandemic. The demand for the drug has multiplied ten folds, however, the drug has been in the controversy for its efficacy in the treatment.

Hydroxychloroquine is an anti-malarial drug, which is primarily used to treat acute attacks of malaria. In addition, it is widely used as disease-modifying anti-rheumatic drug (DMARD).

Hydroxychloroquine-Market,-2020-2027

India is one of the largest producers of hydroxychloroquine. The potential of this drug in treating COVID-19 enforced India to impose a ban on the export of the drug, which led to tension in U.S.–India diplomatic relations. At present, around 80 nations across the globe are dependent on the medication on India.

The key players operating in the hydroxychloroquine industry are Cadila Healthcare Ltd., Hikma Pharmaceuticals PLC, Ipca Laboratories Ltd., Mylan N.V., Novartis AG, Pfizer Inc., Sanofi S.A., Taj Pharmaceuticals Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., and Zydus Cadila. The players are continuously focusing on R&D toward finding the impact of several coatings on coronavirus.

Hydroxychloroquine Market
By Product Type

Your browser does not support the canvas element.

Tablets is projected as the most lucrative segment.

Get more information on this report : Request Sample Pages

Hydroxychloroquine Market, by Product type  

Depending on product type, the market is bifurcated in tablet and active pharmaceutical ingredients. The active pharmaceutical ingredients segment dominated the market in 2019. However, tablet segment is attributed to the easy availability of the product in tablet form thus, is expected to grow at higher CAGR. In addition, surge in high demand for tablet, owing to its cost-effectiveness and ease of consumption drives the hydroxychloroquine market growth.

Hydroxychloroquine Market
By Distribution Channel

Your browser does not support the canvas element.

Online Pharmacy is projected as the most lucrative segment.

Get more information on this report : Request Sample Pages

Hydroxychloroquine Market, by Distribution Channel 

On the basis of distribution channel, the market is divided into hospital pharmacy, online pharmacy, specialty drug store, and retail pharmacy. The online pharmacy segment is projected to witness a considerable growth rate during the forecast period, due to continuous expansion the e-commerce sector. Increase in penetration of e-commerce sector in the pharmaceutical industry during the outbreak, lack of availability of the medicine in hospital pharmacy & retail pharmacy, time-saving feature, and the facility of home delivery provided by online platforms during the lockdown contribute toward the market growth.

Hydroxychloroquine Market
By Application

Your browser does not support the canvas element.

Malaria is projected as the most lucrative segment.

Get more information on this report : Request Sample Pages

Hydroxychloroquine Market, by Disease

By disease, the malaria segment is projected to hold largest hydroxychloroquine market share in 2019. This is attributed to alarming increase in prevalence of malaria and widespread use of hydroxychloroquine as an anti-malarial drug. Moreover, there are still countries in African region considered as malaria endemic, that still drives the demand for the drug. In-addition, HCQ is also listed under essential medicine by World Health organization.

Hydroxychloroquine Market
By Region

2027
Asia-pacific 
Europe
Lamea

Asia-Pacific is projected as the most lucrative market.

Get more information on this report : Request Sample Pages

Hydroxychloroquine Market, by Region

Region wise, Asia-Pacific held the largest market share in 2019. The dominance of the Asia-Pacific region is attributed to the presence of major market players like India and China in this region and surge in demand for the medication due to high incidence rate of malaria in South-east Asian countries.

Key Benefits For Stakeholders

  • The report provides an in-depth analysis and hydroxychloroquine market forecast along with the current trends and future estimations.
  • This report highlights the key drivers, opportunities, and restraints of the hydroxychloroquine market along with the impact analysis during the forecast period.
  • Porter’s five forces analysis helps to analyze the potential of the buyers & suppliers and the competitive scenario of the hydroxychloroquine industry for strategy building.
  • A comprehensive analysis of the factors that drive and restrain the hydroxychloroquine market growth is provided.
  • The qualitative data about the hydroxychloroquine market trends, dynamics, and developments is provided in the report.
  • The hydroxychloroquine market size is provided in terms of revenue.
  • The report provides extensive qualitative insights on the segments and regions exhibiting favorable market share.

Hydroxychloroquine Market Report Highlights

Aspects Details
BY PRODUCT TYPE
  • Tablet
  • Active pharmaceutical ingredients
BY DISTRIBUTION CHANNEL
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Specialty Drug Store
BY DISEASES
  • Malaria
  • Rheumatoid Arthritis
  • Lupus Erythematosus
  • Coronavirus
  • Others
BY REGION
  • North America  (U.S, Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Cadila Healthcare Limited, Hikma Pharmaceuticals PLC, IPCA Laboratories Ltd, Mylan N.V, Novartis International AG, Pfizer Inc, Sanofi S.A, Taj Pharma Group, Teva Pharmaceutical Industries Ltd, Torrent Pharmaceuticals Limited
 

Loading Table Of Content...


 
 

In recent times, with the COVID-19 outbreak, hydroxychloroquine demonstrated anti-viral activity against (SARS–CoV-2). Hydroxychloroquine, in combination with antibiotic azithromycin, holds the potential to treat COVID-19. In India, hydroxychloroquine is an over-the-counter drug, which can purchased without prescription, and is considered among the inexpensive medications. However, since the COVID-19 outbreak, purchasing the drug without prescription has been restricted. The growth of industry is majorly driven by such as rise in demand for the medication, globally. However, several side effects associated with the drug such as hypokalemia, drowsiness, headache, conduction disorders, rhythm, cardiovascular collapse restrain the growth of the hydroxychloroquine market. Intas Pharmaceuticals Ltd., an Indian company operating in Ahmedabad, announced its collaboration with World Health Organization-endorsed study in March 2020. Under the collaboration, the company is planning to supply around two million tablets. Zydus Cadila and IPCA Laboratories announced in April 2020 that they received an order of 10 crore tablets for the treatment of the condition from the Ministry of Health and Family Welfare, India.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The total market size of global Hydroxychloroquine Market is $1,936.5 million in 2019.

A. Cadila Healthcare Ltd., Hikma Pharmaceuticals PLC, Ipca Laboratories Ltd., Mylan N.V., Novartis AG, Pfizer Inc., Sanofi S.A., Taj Pharmaceuticals Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., and Zydus Cadila are the emerging players in the industry.

A. Malaria is the major area of development in the industry followed by rheumatoid arthritis.

A. Malaria and coronavirus are projected to increase demand for Hydroxychloroquine market.

A. Hydroxychloroquine market is driven by increased demand during the pandemic situation. The need for preventing the spread has driven the demand for Hydroxychloroquine further fostering the market growth.

A. The most influencing segment is hospital pharmacy and retail pharmacy in terms of distribution channel.

A. Asia-Pacific holds the maximum market share of the Hydroxychloroquine market.

A. Active pharmaceuticals ingredients are expected to drive the adoption of Hydroxychloroquine.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
RELATED TAGS

Purchase Full Report of
Hydroxychloroquine Market

Start reading instantly.
This Report and over 19,255+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Sep 2021 - Sep 2022)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Sep 2021 - Sep 2022)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Sep 2021 - Sep 2022)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Sep 2021 - Sep 2022)
  • Enterprise
    License/PDF

  • $10,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Sep 2021 - Sep 2022)
  • Library
    Membership

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers